Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01321177 · ClinicalTrials.gov registry record · NA
An Integrated Program for the Treatment of First Episode of Psychosis
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 404
- Enrollment target
NCT01321177 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 404 participants.
The verdict
NCT01321177, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 404 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how services should be provided to reduce symptoms and improve life functioning for adolescents and adults who have been recently diagnosed with schizophrenia.
Interventions
- BEHAVIORAL Integrated Treatment
- BEHAVIORAL Community Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 404 participants |
| Start Date | 2010-07 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01321177
The ClinicalTrials.gov registry entry for NCT01321177 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 404 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Integrated Treatment is the first listed.
NCT01321177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01321177 about?
NCT01321177 is a clinical study titled "An Integrated Program for the Treatment of First Episode of Psychosis". The purpose of this study is to determine how services should be provided to reduce symptoms and improve life functioning for adolescents and adults who have been recently diagnosed with schizophrenia.
What is the current status of trial NCT01321177?
This trial is currently completed. It is a NA study. The enrollment target is 404 participants. The study started on 2010-07. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01321177?
The interventions under investigation include: Integrated Treatment (BEHAVIORAL), Community Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT01321177?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.